CallidusCloud Expands Agreement with Salesforce to Help Customers Sell More, Faster
Feb 06, 2017 13:01 pm UTC| Business
New Partnership Includes Joint Marketing, Sales and Technical Alignment Efforts to Drive Innovation for Customers Globally DUBLIN, Calif., Feb. 06, 2017 -- Callidus Software Inc. (NASDAQ:CALD), the leader in...
Feb 06, 2017 13:01 pm UTC| Business
PRINCETON, N.J., Feb. 06, 2017 -- Advaxis, Inc. (NASDAQ:ADXS), a clinical-stage biotechnology company developing cancer immunotherapies, announced that the first patient has been enrolled and dosed in its AIM2CERV...
Feb 06, 2017 13:01 pm UTC| Business
PRINCETON, N.J., Feb. 06, 2017 -- Advaxis, Inc. (NASDAQ:ADXS), a clinical-stage biotechnology company developing cancer immunotherapies, announced that the first patient has been enrolled and dosed in its AIM2CERV...
Evine to Premiere “Evine Beauty Experience”
Feb 06, 2017 13:01 pm UTC| Business
MINNEAPOLIS, Feb. 06, 2017 -- Evine Live Inc. (“Evine”) (NASDAQ:EVLV), a multiplatform video commerce company (evine.com), today announced that it will premiere “Evine Beauty Experience,” a new weekly program created to...
Evine to Premiere “Evine Beauty Experience”
Feb 06, 2017 13:01 pm UTC| Business
MINNEAPOLIS, Feb. 06, 2017 -- Evine Live Inc. (“Evine”) (NASDAQ:EVLV), a multiplatform video commerce company (evine.com), today announced that it will premiere “Evine Beauty Experience,” a new weekly program created to...
AveXis Announces Single-Arm Design for European Pivotal Study of AVXS-101 in SMA Type 1 Patients
Feb 06, 2017 13:01 pm UTC| Business
CHICAGO, Feb. 06, 2017 -- AveXis, Inc. (NASDAQ:AVXS), a clinical-stage gene therapy company developing treatments for patients suffering from rare and life-threatening neurological genetic diseases, today announced that...
AveXis Announces Single-Arm Design for European Pivotal Study of AVXS-101 in SMA Type 1 Patients
Feb 06, 2017 13:01 pm UTC| Business
CHICAGO, Feb. 06, 2017 -- AveXis, Inc. (NASDAQ:AVXS), a clinical-stage gene therapy company developing treatments for patients suffering from rare and life-threatening neurological genetic diseases, today announced that...